Your browser doesn't support javascript.
loading
Characterization of the GBoV1 Capsid and Its Antibody Interactions.
Yu, Jennifer Chun; Mietzsch, Mario; Singh, Amriti; Jimenez Ybargollin, Alberto; Kailasan, Shweta; Chipman, Paul; Bhattacharya, Nilakshee; Fakhiri, Julia; Grimm, Dirk; Kapoor, Amit; Kucinskaite-Kodze, Indre; Zvirbliene, Aurelija; Söderlund-Venermo, Maria; McKenna, Robert; Agbandje-McKenna, Mavis.
Afiliação
  • Yu JC; Department of Biochemistry and Molecular Biology, Center for Structural Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Mietzsch M; Department of Biochemistry and Molecular Biology, Center for Structural Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Singh A; Department of Biochemistry and Molecular Biology, Center for Structural Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Jimenez Ybargollin A; Department of Biochemistry and Molecular Biology, Center for Structural Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Kailasan S; Department of Biochemistry and Molecular Biology, Center for Structural Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Chipman P; Department of Biochemistry and Molecular Biology, Center for Structural Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Bhattacharya N; Biological Science Imaging Resource, Department of Biological Sciences, Florida State University, Tallahassee, FL 32306, USA.
  • Fakhiri J; Department of Infectious Diseases/Virology, Medical Faculty, BioQuant, University of Heidelberg, 69120 Heidelberg, Germany.
  • Grimm D; Department of Infectious Diseases/Virology, Medical Faculty, BioQuant, University of Heidelberg, 69120 Heidelberg, Germany.
  • Kapoor A; Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43220, USA.
  • Kucinskaite-Kodze I; Department of Immunology and Cell Biology of the Institute of Biotechnology of Vilnius University, 10257 Vilnius, Lithuania.
  • Zvirbliene A; Department of Immunology and Cell Biology of the Institute of Biotechnology of Vilnius University, 10257 Vilnius, Lithuania.
  • Söderlund-Venermo M; Department of Virology, University of Helsinki, 00014 Helsinki, Finland.
  • McKenna R; Department of Biochemistry and Molecular Biology, Center for Structural Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Agbandje-McKenna M; Department of Biochemistry and Molecular Biology, Center for Structural Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Viruses ; 13(2)2021 02 20.
Article em En | MEDLINE | ID: mdl-33672786
ABSTRACT
Human bocavirus 1 (HBoV1) has gained attention as a gene delivery vector with its ability to infect polarized human airway epithelia and 5.5 kb genome packaging capacity. Gorilla bocavirus 1 (GBoV1) VP3 shares 86% amino acid sequence identity with HBoV1 but has better transduction efficiency in several human cell types. Here, we report the capsid structure of GBoV1 determined to 2.76 Å resolution using cryo-electron microscopy (cryo-EM) and its interaction with mouse monoclonal antibodies (mAbs) and human sera. GBoV1 shares capsid surface morphologies with other parvoviruses, with a channel at the 5-fold symmetry axis, protrusions surrounding the 3-fold axis and a depression at the 2-fold axis. A 2/5-fold wall separates the 2-fold and 5-fold axes. Compared to HBoV1, differences are localized to the 3-fold protrusions. Consistently, native dot immunoblots and cryo-EM showed cross-reactivity and binding, respectively, by a 5-fold targeted HBoV1 mAb, 15C6. Surprisingly, recognition was observed for one out of three 3-fold targeted mAbs, 12C1, indicating some structural similarity at this region. In addition, GBoV1, tested against 40 human sera, showed the similar rates of seropositivity as HBoV1. Immunogenic reactivity against parvoviral vectors is a significant barrier to efficient gene delivery. This study is a step towards optimizing bocaparvovirus vectors with antibody escape properties.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Capsídeo / Bocavirus / Gorilla gorilla / Anticorpos Antivirais Limite: Animals / Humans Idioma: En Revista: Viruses Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Capsídeo / Bocavirus / Gorilla gorilla / Anticorpos Antivirais Limite: Animals / Humans Idioma: En Revista: Viruses Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos